Phathom Pharmaceuticals | 4:持股變動聲明-高管 Nabulsi Azmi
Phathom Pharmaceuticals | 4:持股變動聲明-高管 Henderson Molly
Phathom Pharmaceuticals | 4:持股變動聲明-董事 KARBE FRANK
Phathom Pharmaceuticals | 4:持股變動聲明-董事 Parikh Asit
Phathom Pharmaceuticals | 8-K:重大事件
Phathom Pharmaceuticals | SC 13G:超過5%持股股東披露文件-BlackRock, Inc.(5.2%)
Phathom Pharmaceuticals | 10-Q:2024財年三季報
Phathom Pharmaceuticals | 8-K:Phathom Pharmicals公佈2024年第三季度財務業績並提供業務最新情況
Phathom Pharmaceuticals | SCHEDULE 13G/A:其他
Phathom Pharmaceuticals | SCHEDULE 13G:其他
Phathom Pharmaceuticals | SC 13G:超過5%持股股東披露文件-Jennison Associates LLC(10.4%)
Phathom Pharmaceuticals | SC 13G:超過5%持股股東披露文件-BlackRock, Inc.(5.2%)
Phathom Pharmaceuticals | SC 13D/A:超過5%持股股東披露文件(修正)-James N. Topper(18.0%),Patrick J. Heron(18.0%)等
Phathom Pharmaceuticals | 8-K:重大事件
Phathom Pharmaceuticals | 424B5:募資說明書
Phathom Pharmaceuticals | FWP:自由書寫募資說明書
Phathom Pharmaceuticals | 10-Q:2024財年二季報
Phathom Pharmaceuticals | 8-K:Phathom Pharmicals公佈2024年第二季度財務業績並提供業務最新情況
Phathom Pharmaceuticals | 8-K:重大事件
Phathom Pharmaceuticals | 4:持股變動聲明-高管 Nabulsi Azmi